| TEVA 1.63% 2028-10-15 EURTeva Pharmaceutical Finance Netherlands II B.V. | Netherlands | 2028-10-15 | 1.625 | 3.09 |
| TEVA 3.75% 2027-05-09 EURTeva Pharmaceutical Finance Netherlands II B.V. | Israel | 2027-05-09 | 3.750 | 3.19 |
| TEVA 4.13% 2031-06-01 EURTeva Pharmaceutical Finance Netherlands II B.V. | Israel | 2031-06-01 | 4.125 | 3.81 |
| TEVA 4.38% 2030-05-09 EURTeva Pharmaceutical Finance Netherlands II B.V. | Israel | 2030-05-09 | 4.375 | 3.66 |
| TEVA 4.50% 2025-03-01 EURTeva Pharmaceutical Finance Netherlands II B.V. | Netherlands | 2025-03-01 | 4.500 | 0.00 |
| TEVA 4.50% 2025-03-01 EURTeva Pharmaceutical Finance Netherlands II B.V. | Netherlands | 2025-03-01 | 4.500 | 0.00 |
| TEVA 4.50% 2025-03-01 EURTeva Pharmaceutical Finance Netherlands II B.V. | Netherlands | 2025-03-01 | 4.500 | 0.00 |
| TEVA 6.00% 2025-01-31 EURTeva Pharmaceutical Finance Netherlands II B.V. | Netherlands | 2025-01-31 | 6.000 | 0.00 |
| TEVA 6.00% 2025-01-31 EURTeva Pharmaceutical Finance Netherlands II B.V. | Netherlands | 2025-01-31 | 6.000 | 0.00 |
| TEVA 6.00% 2025-01-31 EURTeva Pharmaceutical Finance Netherlands II B.V. | Netherlands | 2025-01-31 | 6.000 | 0.00 |
| TEVA 7.38% 2029-09-15 EURTeva Pharmaceutical Finance Netherlands II B.V. | Israel | 2029-09-15 | 7.375 | 3.67 |
| TEVA 7.88% 2031-09-15 EURTeva Pharmaceutical Finance Netherlands II B.V. | Israel | 2031-09-15 | 7.875 | 4.04 |